The NIH canceled Logan Beyer’s health equity research, saying it was “antithetical to scientific research.” That’s completely ...

A well-planned defensive strategy can position equity portfolios to be resilient in a very harsh market environment.

When the U.S. announced a fresh round of tariffs on April 2, the U.S. economy was still gaining momentum and, in our view, ...

Trump’s order on discipline comes amid a full-force effort at the federal level to root out diversity, equity, and inclusion ...

Hundreds of university researchers in the U.S. have had their National Science Foundation funding abruptly canceled to comply ...

U.S. private-equity exits and their total value rose in the first quarter compared with a year ago, but recent market ...

Many of these grants have been awarded for research on public health equity, transgender healthcare or LGBTQ+ mental health. A public database maintained by Scott Delaney of Harvard and Noam Ross of ...

T. Rowe Price U.S. Equity Research ETF Trading Up 0.2 % T. Rowe Price U.S. Equity Research ETF stock opened at $33.13 on Friday. The company has a fifty day simple moving average of $35.59 and a ...

Yes, I would like to be contacted by a representative to learn more about Bloomberg's solutions and services. Join us for an in-depth session exploring the most powerful ways to enhance your ...

T. Rowe Price U.S. Equity Research Fund earns a High Process Pillar rating. The main driver of the rating is its parent firm's superior long-term risk-adjusted performance, as shown by the firm's ...